Search

Your search keyword '"Deeg, H. Joachim"' showing total 321 results

Search Constraints

Start Over You searched for: Author "Deeg, H. Joachim" Remove constraint Author: "Deeg, H. Joachim" Database ScienceDirect Remove constraint Database: ScienceDirect
321 results on '"Deeg, H. Joachim"'

Search Results

2. Risk prediction for clonal cytopenia: multicenter real-world evidence

5. Oral decitabine–cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study

7. Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial

10. Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)

17. Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50Years or Older with Severe Aplastic Anemia

18. Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study

20. Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia

26. Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes—Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial

31. Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure

34. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

35. SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition

36. Treosulfan-Based Conditioning and Hematopoietic Cell Transplantation for Nonmalignant Diseases: A Prospective Multicenter Trial

42. Safety and Efficacy of Fedratinib in Patients with Primary (P), Post-Polycythemia Vera (Post-PV), and Post-Essential Thrombocythemia (Post-ET) Myelofibrosis (MF) Previously Treated with Ruxolitinib: Primary Analysis of the FREEDOM Trial

45. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita

48. Allogeneic Hematopoietic Cell Transplantation in Patients Age 60-70 Years with De Novo High-Risk Myelodysplastic Syndrome or Secondary Acute Myelogenous Leukemia: Comparison with Patients Lacking Donors Who Received Azacitidine

49. Allogeneic Hematopoietic Cell Transplantation for Advanced Polycythemia Vera and Essential Thrombocythemia

Catalog

Books, media, physical & digital resources